Area of research
Rheumatology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Internal medicine, Ambrisentan, Tadalafil, Combination therapy, and Clinical endpoint.
Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study